Similar Articles
1411 Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma
1412 Optimal surveillance program for hepatocellular carcinoma - getting ready, but not yet
1413 Strategies to increase the resectability of hepatocellular carcinoma
1414 Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma
1415 Application of meta-analysis to specific research fields: Lessons learned
1416 Brassiere wearing and breast cancer risk: A systematic review and meta-analysis
1417 Second line systemic therapies for hepatocellular carcinoma: Reasons for the failure
1418 Immunology of hepatocellular carcinoma
1419 Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma
1420 Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA